Speaker:

  • Prof. Dr. rer. nat. Andreas Zimmer
  • Institute of Molecular Psychiatry
  • University of Bonn
  • Sigmund Freud Str. 25
  • 53127 Bonn

Current events & links


Publications 2015

Ruhl T, Jonas A, Seidel NI, Prinz N, Albayram O, Bilkei-Gorzo A, von der Emde G. (2015). Oxidation and Cognitive Impairment in the Aging Zebrafish. Gerontology, 62(1):47-57.

Gestrich C, Duerr GD, Heinemann JC, Meertz A, Probst C, Roell W, Schiller W, Zimmer A, Bindila L, Lutz B, Welz A, Dewald O. (2015). Activation of Endocannabinoid System Is Associated with Persistent Inflammation in Human Aortic Aneurysm. Biomed Res Int, 2015:456582. doi: 10.1155/2015/456582. Epub 2015 Oct 11.

Schmöle AC, Lundt R, Gennequin B, Schrage H, Beins E, Krämer A, Zimmer T, Limmer A, Zimmer A, Otte DM. (2015). Expression Analysis of CB2-GFP BAC Transgenic Mice. PLoS One. 2015 Sep 25;10(9):e0138986. doi: 10.1371/journal.pone.0138986. eCollection 2015.

Piyanova A, Lomazzo E, Bindila L, Lerner R, Albayram O, Ruhl T, Lutz B, Zimmer A, Bilkei-Gorzo A. (2015). Age-related changes in the endocannabinoid system in the mouse hippocampus. Mech Ageing Dev, 150:55-64.

Kemter AM, Scheu S, Hüser N, Ruland C, Schumak B, Findeiß M, Cheng Z, Assfalg V, Arolt V, Zimmer A, Alferink J. (2015). The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts. Life Sci, 138:29-34.

Zimmer A. (2015). Genetic Manipulation of the Endocannabinoid System. Handb Exp Pharmacol, 231:129-83.

Jenniches I, Zimmer A. (2015). Reply To: The Anxiolytic Actions of 2-Arachidonoylglycerol: Converging Evidence from Two Recent Genetic Endocannabinoid Deficiency Models. Bill Psychiatry, 79(10):858-68.

Jenniches I, Ternes S, Albayram O, Otte DM, Bach K, Bindila L, Michel K, Lutz B, Bilkei-Gorzo A, Zimmer A. (2015). Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels. Biol Psychiatry, 2015 Apr 14. pii: S0006-3223(15)00314-5. doi: 10.1016/j.biopsych.2015.03.033. [Epub ahead of print].

Nozaki C, Markert A, Zimmer A. (2015). Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice. Eur Neuropsychopharmacol, 25(8):1388-96.

Henrich F, Magerl W, Klein T, Greffrath W, Treede RD. (2015). Capsaicin-sensitive C- and A-fibre nociceptors control long-term potentiation-like pain amplification in humans. Brain, 2015 May 4. pii: awv108. [Epub ahead of print].

Sturm M, Becker A, Schroeder A, Bilkei-Gorzo A, Zimmer A. (2015). Effect of chronic corticosterone application on depression-like behavior in C57BL/6N and C57BL/6J mice. Genes Brain Behav, 14(3):292-300.

Rácz I, Nent E, Erxlebe E, Zimmer A. (2015). CB1 receptors modulate affective behaviour induced by neuropathic pain. Brain Res Bull, 114:42-48.

Maccarrone M, Bab I, Bíró T, Cabral GA, Dey SK, Di Marzo V, Konje JC, Kunos G, Mechoulam R, Pacher P, Sharkey KA, Zimmer A. (2015). Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci. 2015 Mar 18. pii: S0165-6147(15)00034-6. doi: 10.1016/j.tips.2015.02.008. [Epub ahead of print].

Di Marzo V, Stella A, Zimmer A. (2015). Endocannabinoid signaling and the deteriorating brain. Nature Rev. Neurosci., 16(1):30-42.

Schmöle AC, Lundt R, Ternes S, Albayram O, Ulas T, Schultze JL, Bano D, Nicotera P, Alferink J, Zimmer A. (2015). Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer's disease mouse model. Neurobiol Aging, 36:710-719.